dsp 4 has been researched along with Parkinson Disease, Secondary in 4 studies
DSP 4: RN given refers to parent cpd
Parkinson Disease, Secondary: Conditions which feature clinical manifestations resembling primary Parkinson disease that are caused by a known or suspected condition. Examples include parkinsonism caused by vascular injury, drugs, trauma, toxin exposure, neoplasms, infections and degenerative or hereditary conditions. Clinical features may include bradykinesia, rigidity, parkinsonian gait, and masked facies. In general, tremor is less prominent in secondary parkinsonism than in the primary form. (From Joynt, Clinical Neurology, 1998, Ch38, pp39-42)
| Timeframe | Studies, this research(%) | All Research% |
|---|---|---|
| pre-1990 | 1 (25.00) | 18.7374 |
| 1990's | 0 (0.00) | 18.2507 |
| 2000's | 1 (25.00) | 29.6817 |
| 2010's | 2 (50.00) | 24.3611 |
| 2020's | 0 (0.00) | 2.80 |
| Authors | Studies |
|---|---|
| Wang, Y | 1 |
| Chen, X | 1 |
| Wang, T | 1 |
| Sun, YN | 1 |
| Han, LN | 1 |
| Li, LB | 1 |
| Zhang, L | 1 |
| Wu, ZH | 1 |
| Huang, C | 1 |
| Liu, J | 1 |
| Delaville, C | 1 |
| Navailles, S | 1 |
| Benazzouz, A | 1 |
| Pérez, V | 1 |
| Sosti, V | 1 |
| Rubio, A | 1 |
| Barbanoj, M | 1 |
| Rodríguez-Alvarez, J | 1 |
| Kulisevsky, J | 1 |
| Nishi, K | 1 |
| Kondo, T | 1 |
| Narabayashi, H | 1 |
1 review available for dsp 4 and Parkinson Disease, Secondary
| Article | Year |
|---|---|
[A mouse model of N-methyl-4-phenyl-1,2,3,6-tetrahydropyridine induced parkinsonism: effect of norepinephrine terminal destruction].
Topics: 1-Methyl-4-phenyl-1,2,3,6-tetrahydropyridine; Animals; Benzylamines; Dopamine; Levodopa; Locomotion; | 1987 |
3 other studies available for dsp 4 and Parkinson Disease, Secondary
| Article | Year |
|---|---|
Additional noradrenergic depletion aggravates forelimb akinesia and abnormal subthalamic nucleus activity in a rat model of Parkinson's disease.
Topics: Action Potentials; Animals; Benzylamines; Disease Models, Animal; Dopamine; Forelimb; Male; Norepine | 2014 |
Effects of noradrenaline and serotonin depletions on the neuronal activity of globus pallidus and substantia nigra pars reticulata in experimental parkinsonism.
Topics: Animals; Benzylamines; Electrophysiological Phenomena; Extracellular Space; Fenclonine; Globus Palli | 2012 |
Modulation of the motor response to dopaminergic drugs in a parkinsonian model of combined dopaminergic and noradrenergic degeneration.
Topics: 3,4-Dihydroxyphenylacetic Acid; Adenosine A2 Receptor Antagonists; Adrenergic Agents; Animals; Antip | 2007 |